After two years of immunotherapy, patients often experience sustained control or remission of cancer. Regular follow-ups are crucial to monitor for any signs of recurrence or side effects. Continued advancements in Chennai’s immunotherapy options aim to provide long-term benefits and improved outcomes for cancer patients post-treatment.